Abstract:Abstract Background Sialic acids are widely distributed in animal tissues, and aberrantly expressed in a variety of cancer types. High expression of sialic acid contributes to tumor aggressiveness by promoting cell proliferation, migration, angiogenesis, and metastasis. Sialidases are responsible for removal of sialic acids from glycoproteins and glycolipids. Methods N-glycomics of bladder cancer cells were detected by MALDI-TOF mass spectrometry. Sialic acid modification in bladder cancer tissue was determined by lectin blot. The down-regulation of NEU1 in bladder cancer cells was determined by high resolution liquid chromatography mass spectrometry (HR LC-MS). The effects of sialidase NEU1 expression on proliferation and apoptosis of human bladder cancer cells were examined by western blot, RT-PCR, confocal imaging and flow cytometry. Moreover, the function of sialic acids on fibronectin-integrin α5β1 interaction were assayed by immunoprecipitation and ELISA. The importance of NEU1 in tumor formation in vivo was performed using BALB/c-nu mice. Expression of NEU1 in primary human bladder cancer tissue samples was estimated using bladder cancer tissue microarray. Results (1) Downregulation of NEU1 was primarily responsible for aberrant expression of sialic acids in bladder cancer cells. (2) Decreased NEU1 expression was correlated with bladder cancer progression. (3) NEU1 overexpression enhanced apoptosis and reduced proliferation of bladder cancer cells. (4) NEU1 disrupted FN-integrin α5β1 interaction and deactivated the Akt signaling pathway. (5) NEU1 significantly suppressed in vivo tumor formation in BALB/c-nu mice. Conclusions Our data showed that NEU1 inhibited cancer cell proliferation, induced apoptosis, and suppressed tumor formation both in vitro and in vivo, by disrupting interaction of FN and integrin β1 and inhibiting the Akt signaling pathway. Our observations indicate that NEU1 is an important modulator of the malignant properties of bladder cancer cells, and is a potential therapeutic target for prognosis and treatment of bladder cancer. Graphical abstract

Neuraminidase-1: A Sialidase Involved in the Development of Cancers and Metabolic Diseases

Neuraminidase-1 (NEU1): Biological Roles and Therapeutic Relevance in Human Disease

Mammalian Neuraminidases in Immune-Mediated Diseases: Mucins and Beyond

NEU1 and NEU3 Sialidase Activity Expressed in Human Lung Microvascular Endothelia

Lysosomal sialidase NEU1, its intracellular properties, deficiency, and use as a therapeutic agent

Progress of Neu1 and Related Signaling Pathway

NEU1 Sialidase Expressed in Human Airway Epithelia Regulates Epidermal Growth Factor Receptor (EGFR) and MUC1 Protein Signaling

Neuraminidase 1 in Cardiovascular Disease

Severe kidney dysfunction in sialidosis mice reveals an essential role for neuraminidase 1 in reabsorption

The role of sialidase Neu1 in respiratory diseases

Sialidase NEU1 suppresses progression of human bladder cancer cells by inhibiting fibronectin-integrin α5β1 interaction and Akt signaling pathway

NEU1 Sialidase Regulates Membrane-tethered Mucin (MUC1) Ectodomain Adhesiveness for Pseudomonas aeruginosa and Decoy Receptor Release

Cellular Translocation and Secretion of Sialidases

Upregulation of sialidase NEU3 in head and neck squamous cell carcinoma associated with lymph node metastasis

Human Airway Epithelia Express Catalytically Active NEU3 Sialidase.

Sialidase NEU3 Contributes to the Invasiveness of Bladder Cancer

Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies.

Neuraminidase 1 is a driver of experimental cardiac hypertrophy

Compound Heterozygous Mutations in the Neuraminidase 1 Gene in Type 1 Sialidosis: A Case Report and Review of Literature

NEU4-mediated desialylation enhances the activation of the oncogenic receptors for the dissemination of ovarian carcinoma

Neuraminidases—Key Players in the Inflammatory Response after Pathophysiological Cardiac Stress and Potential New Therapeutic Targets in Cardiac Disease